Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-11

FDA Approved: ESCITALOPRAM — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves an original-application ANDA for escitalopram from Rising Pharma Holdings, enabling a generic version of the antidepressant. The approval covers it…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

ORIG AP for ESCITALOPRAM (ESCITALOPRAM)